ALTUM SEQUENCING

About

Altum Sequencing operates a liquid-biopsy-based cancer-monitoring platform for real-time, longitudinal tumour monitoring (including minimal residual disease), serving clinicians, hospitals, pharmaceutical companies and clinical research organisations with assays supporting oncology drug development, companion diagnostics and post-treatment monitoring.

Industries served